PT

Priya Tomar

Active Director Director DIN 10256373
DIN 10256373 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Priya Tomar

Data last updated:

Priya Tomar is a Director at Globiotus Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10256373
Primary Designation Director
Industry Pharma
First Appointment 26 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jul 20232023Active

Board colleagues of Priya Tomar

NameDINCompanyDesignation
Indu Singh10256372Globiotus Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Globiotus Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Priya Tomar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priya Tomar

Priya Tomar currently holds 1 directorship: Globiotus Pharmaceutical Private Limited (Director, since 26 Jul 2023).

Priya Tomar was first appointed on 26 Jul 2023 as Director at Globiotus Pharmaceutical Private Limited.

The current boards of Priya Tomar's companies include Indu Singh (Globiotus Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available